ACG Wealth’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $680K | Sell |
5,818
-24
| -0.4% | -$2.98K | 0.16% | 143 |
|
|
2022
Q2 | $687K | Hold |
5,842
| – | – | 0.14% | 150 |
|
|
2022
Q1 | $761K | Sell |
5,842
-683
| -10% | -$89K | 0.14% | 148 |
|
|
2021
Q4 | $996K | Buy |
6,525
+1,013
| +18% | +$157K | 0.14% | 148 |
|
|
2021
Q3 | $891K | Sell |
5,512
-202
| -4% | -$34K | 0.12% | 149 |
|
|
2021
Q2 | $935K | Sell |
5,714
-6,885
| -55% | -$1.06M | 0.12% | 145 |
|
|
2021
Q1 | $1.9M | Buy |
12,599
+58
| +0.5% | +$9.21K | 0.25% | 85 |
|
|
2020
Q4 | $1.9M | Buy |
12,541
+40
| +0.3% | +$5.72K | 0.26% | 82 |
|
|
2020
Q3 | $1.69M | Buy |
12,501
+4,216
| +51% | +$572K | 0.26% | 79 |
|
|
2020
Q2 | $1.13M | Buy |
8,285
+4,690
| +130% | +$598K | 0.18% | 103 |
|
|
2020
Q1 | $387K | Buy |
3,595
+215
| +6% | +$24.8K | 0.07% | 207 |
|
|
2019
Q4 | $407K | Sell |
3,380
-611
| -15% | -$68.2K | 0.06% | 233 |
|
|
2019
Q3 | $397K | Sell |
3,991
-400
| -9% | -$41.9K | 0.06% | 235 |
|
|
2019
Q2 | $479K | Sell |
4,391
-45
| -1% | -$4.79K | 0.06% | 221 |
|
|
2019
Q1 | $496K | Buy |
4,436
+10
| +0.2% | +$1.1K | 0.07% | 206 |
|
|
2018
Q4 | $427K | Sell |
4,426
-620
| -12% | -$65.8K | 0.07% | 199 |
|
|
2018
Q3 | $615K | Buy |
5,046
+200
| +4% | +$23.6K | 0.08% | 172 |
|
|
2018
Q2 | $532K | Sell |
4,846
-163
| -3% | -$17.4K | 0.08% | 166 |
|
|
2018
Q1 | $535K | Sell |
5,009
-145
| -3% | -$16.1K | 0.08% | 177 |
|
|
2017
Q4 | $550K | Sell |
5,154
-240
| -4% | -$25.7K | 0.08% | 187 |
|
|
2017
Q3 | $600K | Sell |
5,394
-222
| -4% | -$23.7K | 0.1% | 152 |
|
|
2017
Q2 | $581K | Sell |
5,616
-216
| -4% | -$21.3K | 0.1% | 178 |
|
|
2017
Q1 | $570K | Buy |
5,832
+108
| +2% | +$10.3K | 0.1% | 158 |
|
|
2016
Q4 | $506K | Buy |
5,724
+240
| +4% | +$21.8K | 0.11% | 147 |
|
|
2016
Q3 | $529K | Hold |
5,484
| – | – | 0.11% | 147 |
|
|
2016
Q2 | $470K | Sell |
5,484
-36
| -0.7% | -$3.23K | 0.1% | 144 |
|
|
2016
Q1 | $480K | Hold |
5,520
| – | – | 0.11% | 139 |
|
|
2015
Q4 | $623K | Buy |
5,520
+654
| +13% | +$71K | 0.14% | 121 |
|
|
2015
Q3 | $492K | Sell |
4,866
-720
| -13% | -$86.4K | 0.13% | 120 |
|
|
2015
Q2 | $687K | Sell |
5,586
-684
| -11% | -$81.9K | 0.17% | 107 |
|
|
2015
Q1 | $718K | Sell |
6,270
-45
| -0.7% | -$4.96K | 0.19% | 104 |
|
|
2014
Q4 | $639K | Sell |
6,315
-210
| -3% | -$20.4K | 0.17% | 109 |
|
|
2014
Q3 | $595K | Sell |
6,525
-2,466
| -27% | -$216K | 0.17% | 111 |
|
|
2014
Q2 | $770K | Buy |
8,991
+1,488
| +20% | +$117K | 0.15% | 109 |
|
|
2014
Q1 | $591K | Buy |
7,503
+168
| +2% | +$14K | 0.18% | 107 |
|
|
2013
Q4 | $555K | Buy |
+7,335
| New | +$520K | 0.14% | 107 |
|
|
2013
Q3 | – | Sell |
-7,809
| Closed | -$453K | – | 115 |
|
|
2013
Q2 | $453K | Buy |
+7,809
| New | +$451K | 0.18% | 93 |
|
Other funds holding IBB
CB
ACG Wealth's IBB Position: Q3 2022 in Review
ACG Wealth reduced its iShares Biotechnology ETF (IBB) stake by 0.41% in Q3 2022, selling an estimated $2.98K and leaving 5,818 shares worth $680K. The position accounts for 0.16% of the portfolio, ranked #143.
ACG Wealth first reported a position in IBB in Q2 2013 and has held it in 37 quarters since. The position peaked at $1.9M in Q4 2020. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.
- ACG Wealth held 5,818 shares of iShares Biotechnology ETF worth $680K as of Q3 2022.
- ACG Wealth sold 24 iShares Biotechnology ETF shares in Q3 2022, an estimated $2.98K.
- iShares Biotechnology ETF made up 0.16% of ACG Wealth's portfolio in Q3 2022, its #143 holding.
- ACG Wealth first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 37 quarters since.
- ACG Wealth's iShares Biotechnology ETF position peaked at $1.9M in Q4 2020.
- 829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.
Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.